Beam Therapeutics Inc.

Historical 13F Holders

Symbol
BEAM
CUSIP
07373V105
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 07373V105 since 12/18/2024, newest first.

Filer % of Class Filed
ARK Investment Management LLC 13G/A Amendment 7
10.0% 8/14/2026
Event 6/30/2026
Farallon Capital Management, L.L.C. 13G/A Amendment 6
10.0% 8/13/2026
Event 6/30/2026
Vanguard Capital Management LLC 13G 5.0% 4/29/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 3 0% 3/26/2026
Event 3/13/2026
State Street Corp 13G 5.2% 2/9/2026
Event 12/31/2025
Farallon Capital Partners, L.P. 13G/A Amendment 5
10.0% 2/5/2026
Event 12/31/2025
FMR LLC 13G/A Amendment 11
12.6% 2/5/2026
Event 12/31/2025
ARK Investment Management LLC 13G/A Amendment 6
12.3% 2/3/2026
Event 12/31/2025
FMR LLC 13G/A Amendment 10
13.6% 11/5/2025
Event 9/30/2025
ARK Investment Management LLC 13G/A Amendment 5
10.4% 8/7/2025
Event 7/31/2025
FMR LLC 13G/A Amendment 9
15.0% 8/6/2025
Event 6/30/2025
ARCH Venture Fund IX, L.P. 13G/A Amendment 4
4.6% 5/15/2025
Event 3/31/2025
Farallon Capital Partners, L.P. 13G/A Amendment 4
10.0% 5/13/2025
Event 3/31/2025
BlackRock, Inc. 13G/A Amendment 4 7.5% 4/17/2025
Event 3/31/2025
FMR LLC 13G/A Amendment 8
10.1% 4/2/2025
Event 3/31/2025
ARCH Venture Fund IX, L.P. 13G/A Amendment 3
5.6% 2/14/2025
Event 12/31/2024
FMR LLC 13G/A Amendment 7
6.6% 2/12/2025
Event 12/31/2024
Farallon Capital Partners, L.P. 13G/A Amendment 3
9.9% 2/5/2025
Event 12/31/2024
ARK Investment Management LLC 13G/A Amendment 4 7.9% 1/10/2025
Event 9/30/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 9 23.2 k $566 k
2026 Q2 287 113 M $4.20 B
2026 Q1 266 108 M $2.58 B
2025 Q4 261 107 M $2.96 B
2025 Q3 239 107 M $2.60 B
2025 Q2 239 109 M $1.85 B
2025 Q1 248 101 M $1.99 B
2024 Q4 243 81.5 M $2.02 B
2024 Q3 234 79.7 M $1.95 B
2024 Q2 229 79.1 M $1.85 B
2024 Q1 243 79.1 M $2.61 B
2023 Q4 203 74.1 M $2.02 B
2023 Q3 208 67.4 M $1.62 B
2023 Q2 210 64.2 M $2.05 B
2023 Q1 225 60.4 M $1.85 B
2022 Q4 228 59.0 M $2.31 B
2022 Q3 243 54.7 M $2.60 B
2022 Q2 213 54.8 M $2.09 B
2022 Q1 254 49.2 M $2.82 B
2021 Q4 246 45.6 M $3.64 B
2021 Q3 241 45.2 M $3.93 B
2021 Q2 253 46.2 M $5.93 B
2021 Q1 233 43.6 M $3.47 B
2020 Q4 171 37.0 M $3.02 B
2020 Q3 86 29.5 M $727 M
2020 Q2 72 27.7 M $776 M
2020 Q1 62 27.2 M $489 M